Clinical Decision Support Systems (CDSS) Market Size, Share, Growth 2023-2028
Global Clinical Decision Support Systems (CDSS) Market Overview 2023-2028
The global clinical decision support systems (CDSS) market size reached US$ 1.50 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 2.36 Billion by 2028, exhibiting a CAGR of 7.70% during 2023-2028.
Clinical decision support systems (CDSS) are technology-based tools that assist healthcare professionals in making clinical decisions for patient care. They use data analytics and medical knowledge to provide evidence-based recommendations, which improve the quality and efficiency of healthcare delivery. They can analyze patient data, such as medical history, lab results, and current medications, to suggest treatment options, identify potential drug interactions, or predict patient risks. They aim to enhance decision-making and optimize patient outcomes by offering real time patient specific guidance. They can be integrated into electronic health records (EHRs) for seamless operation in clinical workflows.
Global Clinical Decision Support Systems (CDSS) Market Trends and Drivers:
The increasing need for tools that can make sense of complex information due to the rising volume of healthcare data represents one of the primary factors driving the demand for CDSS around the world. Moreover, the rising need for customized healthcare solutions for patients is catalyzing the demnad for CDSS to analyze individual patient data for tailored treatments worldwide. In addition, the growing emphasis on streamlining healthcare operations and improving patient outcomes is influencing the market positively. Apart from this, the integration of artificial intelligence (AI), machine learning (ML), cloud computing, and big data analytics in CDSS to analyze large datasets quickly and offer insights is bolstering the market growth.
Global Clinical Decision Support Systems (CDSS) Market 2023-2028 Analysis and Segmentation:
Top Key Players covered in this report are: Athenahealth Inc., Change Healthcare (United Health Group Incorporated), Epic Systems Corporation, General Electric Company, International Business Machines Corporation, Koninklijke Philips N.V., NextGen Healthcare Inc., Oracle Corporation, Siemens Healthineers AG (Siemens AG), Wolters Kluwer N.V., Zynx Health Incorporated (Hearst Business Media Corporation), etc.
The report segmented the market on the basis of region, component, product, type, delivery mode, model, and application.
Component Insights
- Hardware
- Software
- Services
Product Insights
- Integrated CDSS
- Standalone CDSS
Type Insights
- Therapeutic
- Diagnostic
Delivery Mode Insights
- On Premise
- Cloud Based
Model Insights
- Knowledge Based
- Non-Knowledge Based
Application Insights
- Drug Allergy Alerts
- Clinical Guidelines
- Drug-Drug Interactions
- Clinical Reminders
- Others
Regional Insights
- North America
- United States
- Canada
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Key highlights of the report:
- Market Performance (2017-2022)
- Market Outlook (2023- 2028)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Services Private Limited.
134 N 4th St. Brooklyn, NY 11249, USA
Email: [email protected]
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
